欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

埃及药品和医疗保健报告 - 2018年第4季度

Egypt Pharmaceuticals & Healthcare Report - Q4 2018

加工时间:2018-09-05 信息来源:EMIS 索取原文[58 页]
关键词:跨国制药;医疗保健公司;具有吸引力;具有挑战性的投资;医药和医疗保健行业;货币时代;亮点;推动埃及的医疗支出;导致改善提供;专业医疗服务医院
摘 要:

Multinational pharmaceutical and healthcare companies will find Egypt an attractive, yet challenging investment destination. Increasing political will in Egypt to develop the pharmaceutical and healthcare sector are a bright spot at a time when currency issues and an uncertain economic future threaten drugmakers' revenue-earning capabilities. Over the long term, private investments will drive health expenditure in Egypt and lead to an improvement in the delivery of specialised healthcare services in hospitals.


目 录:

Key View

SWOT

Industry Forecast

Pharmaceutical Market Forecast 

Healthcare Market Forecast

Prescription Drug Market Forecast

Patented Drug Market Forecast

Generic Drug Market Forecast

OTC Medicine Market Forecast 

Pharmaceutical Trade Forecast 

Industry Risk/Reward Index

MENA Innovative Pharmaceuticals Risk/Reward Index

Egypt Innovative Pharmaceuticals Risk/Reward Index

Regulatory Development

Regulatory Review

Market Overview

Competitive Landscape

Company Profile

Amoun Pharmaceutical Company (APC

Egyptian International Pharmaceutical Industries Co 

Medical Union Pharmaceuticals

South Egyptian Drug Industries (SEDICO) 

VACSERA

Egypt Demographic Outlook

Pharmaceuticals & Healthcare Glossary

Pharmaceuticals & Healthcare Methodology .


© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服